Results 61 to 70 of about 10,027 (205)

Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy [PDF]

open access: yes, 2012
BACKGROUND: Optimal doses of i.v. glucocorticoids for Graves' orbitopathy (GO) are undefined. METHODS: We carried out a multicenter, randomized, double-blind trial to determine efficacy and safety of three doses of i.v. methylprednisolone in 159 patients
Bernard M   +52 more
core   +1 more source

The role of hormonal imbalance in the development of autoimmune dacryoadenitis in endocrine orbitopathy

open access: yesOftalʹmologiâ, 2014
The authors analyzed the hormonal profile of patients with Graves’ disease and endocrine orbitopathy with or without autoimmune dacryoadenitis.
V. G. Likhvantseva   +4 more
doaj   +3 more sources

Marine–Lenhart Syndrome with Unilateral Orbitopathy and Metastatic Thyroid Papillary Carcinoma to Lymph Node

open access: yesEndocrinology Research and Practice, 2022
Marine–Lenhart syndrome is a name given to the coexistence of Graves’ disease and functional nodules. In this rare syndrome, nodules are mostly benign. The most common extrathyroidal manifestation of Graves’ disease is Graves’ orbitopathy.
Zeliha Yarar   +7 more
doaj  

A Mimicking Situation Of Active Disease In Thyroid Orbitopathy: The Use Of Topical Prostaglandin Analogs

open access: yesVan Tıp Dergisi, 2017
Thyroid orbitopathy is an inflammatory and autoimmune disease of the orbital and periorbital tissues that characterized as developing autoantibodies against thyroid stimulating hormone receptor (TSH-R).
Aydın Yıldız
doaj   +1 more source

Retinal Capillary Density Reduction Contributes to Dysthyroid Optic Neuropathy via an L‐Arginine‐NO Pathway: A Metabonomics and Clinical Trial Study

open access: yesMedComm, Volume 7, Issue 3, March 2026.
Oxidative stress induces endothelial nitric oxide synthase (eNOS) uncoupling and L‐arginine depletion, reducing nitric oxide (NO) bioavailability in vascular endothelium and contributing to decreased retinal capillary density (RCD) in dysthyroid optic neuropathy (DON).
Yunhai Tu   +12 more
wiley   +1 more source

Graves Orbitopathy [PDF]

open access: yesJournal of Osteopathic Medicine, 2020
Stefano, Natali, Paul, Shogan
openaire   +2 more sources

Bioelectronic Technology for Nutritional Research—a Novel In Vitro Platform for a Better Understanding of Human Gut Barrier Absorption

open access: yesAdvanced Biology, Volume 10, Issue 2, February 2026.
This is the first study to demonstrate that the e‐transmembrane gut model provides more accurate physiological predictions than conventional cell culture inserts when tested by the dietary compound butyrate. The bioelectronic e‐transmembrane platform integrates technological and biological optimizations, enabling the hosting of a complex human gut in ...
Verena Stoeger   +12 more
wiley   +1 more source

Results after En Bloc Lateral Wall Decompression Surgery with Orbital Fat Resection in 111 Patients with Graves’ Orbitopathy

open access: yesInternational Journal of Endocrinology, 2015
Purpose. To evaluate the effect of en bloc lateral wall decompression with additional orbital fat resection in terms of exophthalmos reduction and complications. Methods.
Nicole Fichter, Rudolf F. Guthoff
doaj   +1 more source

Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease

open access: yesClinics, 2011
OBJECTIVE: To compare superior ophthalmic vein blood flow parameters measured with color Doppler imaging in patients with congestive Graves' orbitopathy before and after treatment and in normal controls.
Mário L. R. Monteiro   +3 more
doaj   +1 more source

Idiopathic Orbital Inflammation Masquerading as Relapse of Seronegative Juvenile Myasthenia Gravis: A Case Report

open access: yes
Journal of Paediatrics and Child Health, Volume 62, Issue 9, Page 1770-1774, September 2026.
Wenhao Duan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy